Global Health Ltd. announces a new order win

Ghaziabad is an additional, longer-dated capacity option rather than a dated milestone within the existing expansion roadmap. The announcement gives no construction-completion or commissioning date; development remains subject to customary and statutory approvals and Board approval. ^[1]

Medanta’s existing roadmap already includes five upcoming hospitals across Mumbai, Pitampura and South Delhi, Guwahati, and Varanasi. ^[2] Ghaziabad therefore expands the pipeline further, but cannot yet be mapped to a specific commissioning year or treated as operational capacity. The company has not disclosed whether it will be commissioned before or after those projects.

Bed-count implication

• Current operational network: 3,737 installed beds across six hospitals as of June 30, 2026. ^[2]
• Ghaziabad proposal: 350+ beds, subject to approvals. ^[1]
• Implied network capacity after Ghaziabad becomes operational: 4,087+ beds, derived from 3,737 existing beds plus 350+ proposed beds. ^{[2] [1]}

This 4,087+ figure is a potential post-commissioning capacity, not current installed or operational beds. It also excludes the bed capacity of the five other upcoming hospitals, for which no bed counts are provided in the announcement.

Ghaziabad’s disclosed capital intensity is below Rs 47.38 lakh per planned bed on a land-only basis, calculated as the approximately Rs 165.82 Crore land cost divided by the proposed 350+ beds. Because the bed count is “350+”, the actual land cost per bed would be lower than this ceiling; this excludes construction, medical equipment, pre-opening and other project costs. ^[1]

A like-for-like comparison with Patna or Noida cannot be established from the announcement: it does not provide their project cost, bed capacity or comparable total-capex-per-bed figures. The Ghaziabad number should therefore not be interpreted as total hospital capital intensity.

The targeted gestation period for EBITDA break-even for Ghaziabad is not stated. The project remains proposed and is subject to customary/statutory approvals and Board approval, so assigning a break-even timeline would be speculative. ^[1]